In another mouse model, we show that C. comes gavage does not lead to a reduction in liver disease markers, such as liver–body weight ratio, hepatic triglycerides, or ALT, even though it produces the highest levels of butyrate in relation to the bacterial strains isolated in the prior experiment and the control strains (Figure 3b and Figure 5a–f). The gene discussed is GPT; the disease is liver disorder.